These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 16372880

  • 1. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.
    Murphy TF.
    Expert Rev Vaccines; 2005 Dec; 4(6):843-53. PubMed ID: 16372880
    [Abstract] [Full Text] [Related]

  • 2. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA.
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [Abstract] [Full Text] [Related]

  • 3. Current progress with Moraxella catarrhalis antigens as vaccine candidates.
    Mawas F, Ho MM, Corbel MJ.
    Expert Rev Vaccines; 2009 Jan; 8(1):77-90. PubMed ID: 19093775
    [Abstract] [Full Text] [Related]

  • 4. Vaccines for Moraxella catarrhalis and non-typeable Haemophilus influenzae.
    McMichael JC, Green BA.
    Curr Opin Investig Drugs; 2003 Aug; 4(8):953-8. PubMed ID: 14508879
    [Abstract] [Full Text] [Related]

  • 5. Recent advances in otitis media. 6. Vaccine.
    Giebink GS, Kurono Y, Bakaletz LO, Kyd JM, Barenkamp SJ, Murphy TF, Green B, Ogra PL, Gu XX, Patel JA, Heikkinen T, Pelton SI, Hotomi M, Karma P.
    Ann Otol Rhinol Laryngol Suppl; 2005 Jan; 194():86-103. PubMed ID: 15700938
    [No Abstract] [Full Text] [Related]

  • 6. Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia.
    Watson K, Carville K, Bowman J, Jacoby P, Riley TV, Leach AJ, Lehmann D, Kalgoorlie Otitis Media Research Project Team.
    Pediatr Infect Dis J; 2006 Sep; 25(9):782-90. PubMed ID: 16940834
    [Abstract] [Full Text] [Related]

  • 7. The promise of immunoprophylaxis for prevention of acute otitis media.
    Pelton SI, Klein JO.
    Pediatr Infect Dis J; 1999 Oct; 18(10):926-35. PubMed ID: 10530593
    [No Abstract] [Full Text] [Related]

  • 8. Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia.
    Andrade DC, Borges IC, Adrian PV, Meinke A, Barral A, Ruuskanen O, Käyhty H, Nascimento-Carvalho CM.
    Pediatr Infect Dis J; 2016 Jun; 35(6):683-9. PubMed ID: 26954601
    [Abstract] [Full Text] [Related]

  • 9. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 10. Moraxella catarrhalis, a human respiratory tract pathogen.
    Murphy TF, Parameswaran GI.
    Clin Infect Dis; 2009 Jul 01; 49(1):124-31. PubMed ID: 19480579
    [Abstract] [Full Text] [Related]

  • 11. Vaccine targets against Moraxella catarrhalis.
    Ren D, Pichichero ME.
    Expert Opin Ther Targets; 2016 Jul 01; 20(1):19-33. PubMed ID: 26565427
    [Abstract] [Full Text] [Related]

  • 12. Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development.
    Jalalvand F, Riesbeck K.
    Expert Rev Vaccines; 2018 Jun 01; 17(6):503-512. PubMed ID: 29863956
    [Abstract] [Full Text] [Related]

  • 13. A fluorescent multiplexed bead-based immunoassay (FMIA) for quantitation of IgG against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis protein antigens.
    Andrade DC, Borges IC, Laitinen H, Ekström N, Adrian PV, Meinke A, Barral A, Nascimento-Carvalho CM, Käyhty H.
    J Immunol Methods; 2014 Mar 01; 405():130-43. PubMed ID: 24530690
    [Abstract] [Full Text] [Related]

  • 14. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
    Murphy TF.
    Clin Vaccine Immunol; 2015 May 01; 22(5):459-66. PubMed ID: 25787137
    [Abstract] [Full Text] [Related]

  • 15. Seasonal distribution of otitis media pathogens among Costa Rican children.
    Guevara S, Soley C, Arguedas A, Porat N, Dagan R.
    Pediatr Infect Dis J; 2008 Jan 01; 27(1):12-6. PubMed ID: 18162931
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nontypeable Haemophilus influenzae as a pathogen in children.
    Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, Virji M, Pelton SI.
    Pediatr Infect Dis J; 2009 Jan 01; 28(1):43-8. PubMed ID: 19057458
    [Abstract] [Full Text] [Related]

  • 18. Monophosphoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable Haemophilus influenzae and Moraxella catarrhalis from the nasopharynx in mice.
    Hirano T, Kodama S, Kawano T, Maeda K, Suzuki M.
    FEMS Immunol Med Microbiol; 2011 Dec 01; 63(3):407-17. PubMed ID: 22092567
    [Abstract] [Full Text] [Related]

  • 19. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
    Forsgren A, Riesbeck K, Janson H.
    Clin Infect Dis; 2008 Mar 01; 46(5):726-31. PubMed ID: 18230042
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of culture and polymerase chain reaction methods for the detection of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis in cerebrospinal fluids and middle ear effusions].
    Jbara I, Baysallar M, Kiliç A, Yetişer S, Unay B, Açikel C, Yapar M, Doğanci L.
    Mikrobiyol Bul; 2007 Oct 01; 41(4):495-502. PubMed ID: 18173067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.